1987EnshoOpen access

Colchicine.

I Akaoka, Akiteru Takeuchi

Open full text 0 citations

Abstract

The pharmacological mechanism, and adverse effect of colchicine are described. In addition diseases which are treated with colchicine are also reported. Colchicine inhibits chemotaxis of polymorphonuclear leukocytes by blocking the assembly of microtubules. Colchicine is effective in Behcet's disease, primary biliary cirrhosis, amyloidosis, and gout. One mg of colchicine is enough as an initial dose at acute attack of gout. Colchicine should be continued for additional couple of days. There had been no effective medicines for the ocular symptoms of Behcet's disease. However, almost two-thirds of the patients with this disease responded well to colchicine. And today many doctors prescribe colchicine for the treatment of Behcet's disease. Colchicine might be used for other intractable diseases.

Open-access reader

About this research paper

What this paper is about

The pharmacological mechanism, and adverse effect of colchicine are described. In addition diseases which are treated with colchicine are also reported. Colchicine inhibits chemotaxis of polymorphonuclear leukocytes by blocking the assembly of microtubules. Colchicine is effective in Behcet's disease, primary biliary cirrhosis, amyloidosis, and gout. One mg of colchicine is enough as an initial dose at acute attack of gout. Colchicine should be continued for additional couple of days. There had been no effective medicines for the ocular symptoms of Behcet's disease. However, almost two-thirds of the patients with this disease responded well to colchicine. And today many doctors prescribe colchicine for the treatment of Behcet's disease. Colchicine might be used for other intractable diseases.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The pharmacological mechanism, and adverse effect of colchicine are described. In addition diseases which are treated with colchicine are also reported. Colchicine inhibits chemotaxis of polymorphonuclear leukocytes by blocking the assembly of microtubules. Colchicine is effective in Behcet's disease, primary biliary cirrhosis, amyloidosis, and gout. One mg of colchicine is enough as an initial dose at acute attack of gout. Colchicine should be continued for additional couple of days. There had been no effective medicines for the ocular symptoms of Behcet's disease. However, almost two-thirds of the patients with this disease responded well to colchicine. And today many doctors prescribe colchicine for the treatment of Behcet's disease. Colchicine might be used for other intractable diseases.

Key concepts: Colchicine, Gout, Medicine, Adverse effect, Vinca, Internal medicine, Gastroenterology, Dermatology

Related papers

Back to paper searchBrowse research topicsOriginal source
Colchicine. — Research Paper | ScholarLens